Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later
- PMID: 3908280
Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later
Abstract
The Paris Prospective Study is a long-term investigation of cardiovascular diseases in a population of 7164 working men, aged 43-54 years. The first annual follow-up session (1968-73) included a 0-2 hr 75 g OGTT with measurement of plasma insulin and glucose levels beside the major coronary heart disease (CHD) risk factors: arterial pressure, cigarette smoking, weight, cholesterol, triglycerides. After a mean 11.2 years follow-up, 651 deaths, among them 126 due to CHD, were recorded. The annual CHD mortality rates were respectively 1.4, 2.7 and 3.2 per 1000 for the 6055 normoglycaemic, 690 impaired glucose tolerance, and 293 new and known diabetic subjects (1980 WHO classification) (p less than 0.01). The annual risk was analyzed by the multivariate Cox model. It showed that the fasting plasma insulin was positively associated with risk independent of the other factors (p less than 0.05), whereas glucose tolerance, including overt diabetes, was not significantly associated. We conclude that high insulin levels may constitute a more sensitive predictor of CHD than the degree of glucose intolerance, it could be useful to avoid excessive insulin plasma concentration, and even to lower its level.
Similar articles
-
[Diabetes, hyperglycemia, hyperinsulinemia and risk of cardiovascular mortality. Findings of the Paris Prospective Survey, 10 years later].Rev Epidemiol Sante Publique. 1985;33(4-5):352-7. Rev Epidemiol Sante Publique. 1985. PMID: 4095333 French.
-
Insulin-resistance, hypertriglyceridaemia and cardiovascular risk: the Paris Prospective Study.Diabete Metab. 1991 May;17(1 Pt 2):93-5. Diabete Metab. 1991. PMID: 1936489
-
Hyperinsulinaemia as predictor of atherosclerotic vascular disease: epidemiological evidence.Diabete Metab. 1991 May;17(1 Pt 2):87-92. Diabete Metab. 1991. PMID: 1834487
-
[Risk factors for atherosclerotic diseases in the Prospective Parisian Study I. Comparison with foreign studies].Rev Epidemiol Sante Publique. 1985;33(2):108-20. Rev Epidemiol Sante Publique. 1985. PMID: 3898252 Review. French.
-
Diabetes and the heart: coronary heart disease.Clin Endocrinol Metab. 1977 Jul;6(2):389-402. doi: 10.1016/s0300-595x(77)80044-3. Clin Endocrinol Metab. 1977. PMID: 330040 Review.
Cited by
-
Random fasting hyperglycemia as cardiovascular risk factor in the elderly: a 6-year longitudinal study.Clin Cardiol. 2001 Apr;24(4):341-4. doi: 10.1002/clc.4960240416. Clin Cardiol. 2001. PMID: 11303705 Free PMC article.
-
Vegetarian Diet in Chronic Kidney Disease-A Friend or Foe.Nutrients. 2017 Apr 10;9(4):374. doi: 10.3390/nu9040374. Nutrients. 2017. PMID: 28394274 Free PMC article. Review.
-
Insulin promotes macrophage foam cell formation: potential implications in diabetes-related atherosclerosis.Lab Invest. 2012 Aug;92(8):1171-80. doi: 10.1038/labinvest.2012.74. Epub 2012 Apr 23. Lab Invest. 2012. PMID: 22525426 Free PMC article.
-
What should we measure in the diabetic patient and how does this respond to therapy?Br J Clin Pharmacol. 2002 Jul;54(1):81-6. doi: 10.1046/j.1365-2125.2002.01624.x. Br J Clin Pharmacol. 2002. PMID: 12100231 Free PMC article. Review. No abstract available.
-
Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus.Drugs Aging. 2000 Dec;17(6):463-76. doi: 10.2165/00002512-200017060-00004. Drugs Aging. 2000. PMID: 11200307 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical